Transaction · 0000914190-26-000130

Geist William

Geist William, PRES, PS, reported a transaction classified as grant at BIO-TECHNE Corp involving 23985.000000 shares for an estimated $0.00. Reported holdings after the transaction were 23985.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES, PS
TECHBIO-TECHNE Corp
Trade date
Aug 17, 2026
Filing date
Aug 19, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded23.9k$0.00 per share
Holdings after23.9kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TECH price since this filing

Daily closing prices, with the filing date and available return windows
TECH · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -0.5%1w ago -0.5%1d ago -0.1%
Returns since7d -0.1%30d -0.1%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0000914190-26-000130
Restricted Stock Units
Transaction date
Aug 17, 2026
Filed Aug 19, 2026, 08:47 PM · 2d delay
Shares
23,985 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
23,985 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT, PROTEIN SCIENCES

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    100% vested.

  2. F2

    Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026.

  3. F3

    Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.

  4. F4

    Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.

  5. F5

    Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

  6. F6

    Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  7. F7

    Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

  8. F8

    2,623 restricted stock units vest on 8/15/2027.

  9. F9

    3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028.

  10. F10

    4,921 restricted stock units vest on each of 8/17/2027 and 8/17/2028, and 4,920 restricted stock units vest on 8/17/2029.

  11. F11

    23,985 restricted stock units vest on 8/17/2029.

Original filing · 0000914190-26-000130
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TECH